[HTML][HTML] Fenofibrate for COVID-19 and related complications as an approach to improve treatment outcomes: the missed key for Holy Grail

SS Alkhayyat, HM Al-Kuraishy, AI Al-Gareeb… - Inflammation …, 2022 - Springer
Introduction Fenofibrate is an agonist of peroxisome proliferator activated receptor alpha
(PPAR-α), that possesses anti-inflammatory, antioxidant, and anti-thrombotic properties …

Fenofibrate for COVID-19 and related complications as an approach to improve treatment outcomes: the missed key for Holy Grail

SS Alkhayyat, HM Al-kuraishy… - Inflammation …, 2022 - search.proquest.com
Results By destabilizing SARS-CoV-2 spike protein and preventing it from binding
angiotensin-converting enzyme 2 (ACE2), a receptor for SARS-CoV-2 entry, fenofibrate can …

[HTML][HTML] Fenofibrate for COVID-19 and related complications as an approach to improve treatment outcomes: the missed key for Holy Grail

SS Alkhayyat, HM Al-kuraishy, AI Al-Gareeb… - Inflammation …, 2022 - ncbi.nlm.nih.gov
Results By destabilizing SARS-CoV-2 spike protein and preventing it from binding
angiotensin-converting enzyme 2 (ACE2), a receptor for SARS-CoV-2 entry, fenofibrate can …

Fenofibrate for COVID-19 and related complications as an approach to improve treatment outcomes: the missed key for Holy Grail.

SS Alkhayyat, HM Al-kuraishy… - Inflammation …, 2022 - search.ebscohost.com
Introduction: Fenofibrate is an agonist of peroxisome proliferator activated receptor alpha
(PPAR-α), that possesses anti-inflammatory, antioxidant, and anti-thrombotic properties …

Fenofibrate for COVID-19 and related complications as an approach to improve treatment outcomes: the missed key for Holy Grail.

SS Alkhayyat, HM Al-Kuraishy… - … : Official Journal of the …, 2022 - europepmc.org
Results By destabilizing SARS-CoV-2 spike protein and preventing it from binding
angiotensin-converting enzyme 2 (ACE2), a receptor for SARS-CoV-2 entry, fenofibrate can …

Fenofibrate for COVID-19 and related complications as an approach to improve treatment outcomes: the missed key for Holy Grail.

SS Alkhayyat, HM Al-Kuraishy, AI Al-Gareeb… - 2022 - cabidigitallibrary.org
Introduction: Fenofibrate is an agonist of peroxisome proliferator activated receptor alpha
(PPAR-α), that possesses anti-inflammatory, antioxidant, and anti-thrombotic properties …

Fenofibrate for COVID-19 and related complications as an approach to improve treatment outcomes: the missed key for Holy Grail

SS Alkhayyat, HM Al-kuraishy… - Inflammation …, 2022 - investigo.biblioteca.uvigo.es
Introduction Fenofbrate is an agonist of peroxisome proliferator activated receptor alpha
(PPAR-α), that possesses antiinfammatory, antioxidant, and anti-thrombotic properties …

Fenofibrate for COVID-19 and related complications as an approach to improve treatment outcomes: the missed key for Holy Grail

SS Alkhayyat, HM Al-kuraishy… - Inflammation …, 2022 - investigo.biblioteca.uvigo.es
Introduction Fenofbrate is an agonist of peroxisome proliferator activated receptor alpha
(PPAR-α), that possesses antiinfammatory, antioxidant, and anti-thrombotic properties …

Fenofibrate for COVID-19 and related complications as an approach to improve treatment outcomes: the missed key for Holy Grail

SS Alkhayyat, HM Al-Kuraishy… - … : official journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction Fenofibrate is an agonist of peroxisome proliferator activated receptor alpha
(PPAR-α), that possesses anti-inflammatory, antioxidant, and anti-thrombotic properties …